Poor prognosis in acute lymphoblastic leukemia may relate to promoter hypermethylation of cancer-related genes.
about
Molecular detection of B-cell neoplasms by specific DNA methylation biomarkersEpigenetic inactivation of Notch-Hes pathway in human B-cell acute lymphoblastic leukemia.Rationales for expression and altered expression of apoptotic protease activating factor-1 gene in gastric cancer.Epigenetics in systemic lupus erythematosus: leading the way for specific therapeutic agentsTargeting paediatric acute lymphoblastic leukaemia: novel therapies currently in developmentDissecting DNA hypermethylation in cancer.Potential roles of microRNA-29a in the molecular pathophysiology of T-cell acute lymphoblastic leukemia.DNA methylation: its role in cancer development and therapy.Adult acute lymphoblastic leukemia: concepts and strategies.T-cell acute lymphoblastic leukaemia: recent molecular biology findings.Pharmacogenomic considerations of xenograft mouse models of acute leukemia.Pediatric relapsed or refractory leukemia: new pharmacotherapeutic developments and future directions.Novel targeted therapies in acute lymphoblastic leukemia.Philadelphia chromosome-negative acute lymphoblastic leukemia: therapies under development.The Central Role for Microenvironment in B-Cell Malignancies: Recent Insights into Synergistic Effects of its Therapeutic Targeting and Anti-CD20 Antibodies.Current status and future directions of T-lymphoblastic lymphoma in children and adolescents.Significance of Inactivated Genes in Leukemia: Pathogenesis and PrognosisSilencing of TESTIN by dense biallelic promoter methylation is the most common molecular event in childhood acute lymphoblastic leukaemiaA putative "hepitype" in the ATM gene associated with chronic lymphocytic leukemia risk.CpG island methylator phenotype of myelodysplastic syndrome identified through genome-wide profiling of DNA methylation and gene expression.Deregulation of FGFR1 and CDK6 oncogenic pathways in acute lymphoblastic leukaemia harbouring epigenetic modifications of the MIR9 family.
P2860
Q28394142-258EC9B1-71FA-4056-AD5D-AD4349F160BDQ34700660-EE3328A5-13B9-45A7-B988-A2A9FE54827FQ35615797-141F1461-EA2C-4D15-B37E-11D39BFECA9CQ35620090-F96C684C-DA82-42B8-B853-AD652C0168DDQ35967452-DF3FE144-C415-4561-B607-3B17E618D776Q36041771-28D5A75F-9B9D-45AF-8B31-78637176AF2DQ36262865-8AA8C93D-9E61-41F3-AEF8-F6067B550014Q36986433-90B4F13C-B9B4-452A-9AC0-5F2F9A8E6054Q37681450-52DD64E0-8E73-4DD5-887C-E7C4F5A02B4DQ37965247-7A3A36ED-5A55-42D2-B8EA-47CE06D81A03Q38061500-9E81BBDE-D2FB-4C43-89FE-422760756EEAQ38097334-8C6F5F5F-BD39-4C1F-B4EB-61C48DED19A0Q38120551-25004561-3C63-4940-BAD5-DD527D2F9F8BQ38282458-D73EF217-45FB-4C2E-8CDA-ABEDAC6EF70DQ38577849-318262BE-A183-4971-B9D9-AB5720D71706Q38779952-405B155C-D151-4987-BBD1-FEE9A18022FEQ39350173-19699BEC-B0E0-4F4A-9851-489FBADB1E10Q39396703-B589ABE9-184F-456D-AD73-E26C510045E7Q47266960-15014060-47D4-4394-9CD5-2A5CDEB5DE2EQ54219654-11836036-A206-4517-B638-6DBF994F7B12Q54570256-C19718D4-3BFD-4CE2-BBE3-AB17D3F57099
P2860
Poor prognosis in acute lymphoblastic leukemia may relate to promoter hypermethylation of cancer-related genes.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Poor prognosis in acute lympho ...... ation of cancer-related genes.
@en
type
label
Poor prognosis in acute lympho ...... ation of cancer-related genes.
@en
prefLabel
Poor prognosis in acute lympho ...... ation of cancer-related genes.
@en
P2093
P2860
P1433
P1476
Poor prognosis in acute lympho ...... ation of cancer-related genes.
@en
P2093
Anabel Heiniger
Antonio Jimenez-Velasco
Antonio Torres
Felipe Prosper
Jose Roman-Gomez
Manuel Barrios
P2860
P304
P356
10.1080/10428190701344899
P577
2007-07-01T00:00:00Z